Progentec Diagnostics, Inc. — Form D/A
Progentec Diagnostics, Inc. of OKLAHOMA CITY, OK, a company, filed a Form D amendment with the SEC on 2018-11-21. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-21
- Form: D/A
- Accession: 0001722842-18-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $2.5M
- Amount sold: $2.5M
- Minimum investment: $75K
- Investors: 7
- Date of first sale: 2017-11-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-299302
Issuer
- Name: Progentec Diagnostics, Inc.
- CIK: 0001722842
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 825 N.E. 13TH STREET, OKLAHOMA CITY, OK, 73104
- Phone: 4052164818
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Mohan Purushothaman | Director | Oklahoma City, OK |
| Robert Saunders | Director | Chicago, IL |
| Sanjiv Sharma | Director | Oklahoma City, OK |
| Mohan Purushothaman | Executive Officer | Oklahoma City, OK |
| Sanjiv Sharma | Executive Officer | Oklahoma City, OK |
Other filings by this issuer (1)
More